Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.

[1]  S. Briançon,et al.  Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  A. Chapman,et al.  Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  B. Lima,et al.  Results of Proximal Arch Replacement Using Deep Hypothermia for Circulatory Arrest: Is Moderate Hypothermia Really Justifiable? , 2011, The American surgeon.

[4]  G. Biondi-Zoccai,et al.  Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. , 2011, Journal of cardiothoracic and vascular anesthesia.

[5]  J. Toole,et al.  Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. , 2011, The Journal of thoracic and cardiovascular surgery.

[6]  B. Phillips-Bute,et al.  Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. , 2011, The Journal of thoracic and cardiovascular surgery.

[7]  B. Billah,et al.  The Safety of Recombinant Factor VIIa in Cardiac Surgery , 2010, Anaesthesia and intensive care.

[8]  C. González,et al.  The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications? , 2010, Thrombosis journal.

[9]  C. Willis,et al.  Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes , 2010, Vox sanguinis.

[10]  M. Lachat,et al.  Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation. , 2010, The Annals of thoracic surgery.

[11]  R. Wynne,et al.  Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery. , 2009, Interactive cardiovascular and thoracic surgery.

[12]  F. Sellke,et al.  Safety and Efficacy of Recombinant Activated Factor VII: A Randomized Placebo-Controlled Trial in the Setting of Bleeding After Cardiac Surgery , 2009, Circulation.

[13]  K. Stuebing,et al.  Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. , 2009, Journal of cardiothoracic and vascular anesthesia.

[14]  W. Beattie,et al.  Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery , 2008, Circulation.

[15]  G. Gensini,et al.  Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  F. Pellegrini,et al.  Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: A propensity score analysis* , 2007, Critical care medicine.

[17]  E. V. van Dongen,et al.  Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients. , 2006, Journal of cardiothoracic and vascular anesthesia.

[18]  D. Monroe,et al.  Recombinant activated factor VII and the anaesthetist , 2005, Anaesthesia.

[19]  D. O'shaughnessy,et al.  Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. , 2005, British journal of anaesthesia.

[20]  K. Wernecke,et al.  Recombinant activated factor VII for refractory bleeding after cardiac surgery—A retrospective analysis of safety and efficacy , 2005, Critical Care Medicine.

[21]  S. McCluskey,et al.  Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score–matched case‐control analysis , 2005, Transfusion.